MAY 08, 2024 7:00 AM PDT

Advancing cancer organoid drug screening with novel media systems

Sponsored by: Thermo Fisher Scientific

Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will discuss the capabilities of OncoPro medium, a novel system that simplifies the use of tumoroids for drug screening applications. This session will review potential areas of optimization and highlight how OncoPro medium mitigates these challenges. In the second half, Christophe Deben from Orbits will lead us through the cutting edge of imaging software. He will demonstrate how their technology effectively resolves downstream bottlenecks in high content image analysis, providing invaluable insights into the translation of tumoroid and cancer organoid technology for high throughput applications. By participating in these presentations, you will gain a deeper understanding of the current progress and future direction of tumoroid-based drug screening and image analysis techniques. Join us and be at the forefront of these exciting technological advances that are shaping the future of cancer research.
Learning Objectives
  • Learn how cancer organoids can be adopted for high-throughput screening applications
  • Understand areas of optimization in drug screening workflows for improved consistency and reproducibility
  • Learn how image analysis can be improved to better correlate assay results with patient outcomes
Webinars will be available for unlimited on-demand viewing after live event.

You May Also Like
Loading Comments...